Results 221 to 230 of about 1,001,687 (372)

Lymphatic vessel density and function in experimental bladder cancer [PDF]

, 2007
Marcia R. Saban, Rheal A. Towner, Nataliya Smith, Andrew Abbott, Michal Neeman, Carole Davis, Cindy Simpson, Julie Maier, Sylvie Mémet, Xue‐Ru Wu, Ricardo Saban   +10 more
openalex   +1 more source

Accelerated Cellular Senescence in Progressive Multiple Sclerosis: A Histopathological Study

Annals of Neurology, EarlyView.
Objective The neurodegenerative processes driving the build‐up of disability in progressive multiple sclerosis (P‐MS) have not been fully elucidated. Recent data link cellular senescence (CS) to neurodegeneration. We investigated for evidence of CS in P‐MS and sought to determine its pattern.
Dimitrios Papadopoulos, Roberta Magliozzi, Sara Bandiera, Ilaria Cimignolo, Elena Barusolo, Lesley Probert, Vassilis Gorgoulis, Richard Reynolds, Richard Nicholas   +8 more
wiley   +1 more source

Morphological Changes of Lymphatic Vessels in Dextran Sulfate sodium-induced Ulcerative Colitis of Guinea Pigs

, 2000
Sanae ICHIKAWA
openalex   +2 more sources

Lymphangiography: Forgotten Tool or Rising Star in the Diagnosis and Therapy of Postoperative Lymphatic Vessel Leakage [PDF]

, 2007
Sebastian Kos, H. Haueisen, Ulrich Lachmund, T Roeren   +3 more
openalex   +1 more source

Roadmap to Nanomedical Applications: Nanotoxicology and In Vitro Guidelines for Lanthanide‐Doped Luminescence Nanothermometers

Advanced NanoBiomed Research, EarlyView.
Lanthanide‐based luminescence nanothermometry holds multifaceted potential for nanomedical applications, yet despite significant research advances, clinical translation of the engineered nanomaterials is still controversial and widely disputed. This is related to crucial nanotoxicological aspects that must be addressed at the preclinical level ...
Simona Premcheska, Andre G. Skirtach, Anna M. Kaczmarek   +2 more
wiley   +1 more source

A radiological complete response to pembrolizumab in a patient with metastatic upper urinary tract urothelial cancer and Lynch syndrome

IJU Case Reports, Volume 6, Issue 1, Page 33-36, January 2023., 2023
Introduction In Lynch syndrome, urothelial cancer is the third most common cancer, following colorectal and endometrial cancers. Little is known, however, about the efficacy of immune checkpoint inhibitors in the treatment of metastatic urothelial cancer in Lynch syndrome.
Ryosuke Oki, Tetsuya Urasaki, Arisa Ueki, Kentaro Inamura, Yoshinobu Komai, Shunji Takahashi, Junji Yonese, Takeshi Yuasa   +7 more
wiley   +1 more source

A single-cell atlas of normal and KRASG12D-malformed lymphatic vessels. [PDF]

JCI Insight
Fernandes LM, Griswold-Wheeler D, Tresemer JD, Vallejo A, Vishlaghi N, Levi B, Shapiro A, Scallan JP, Dellinger MT.   +8 more
europepmc   +1 more source

Functional Synovium‐Based 3D Models in the Context of Human Disease and Inflammation

Advanced NanoBiomed Research, EarlyView.
The synovium is key to joint function but is often affected by diseases like rheumatoid arthritis. Finding better treatments is challenging because current lab models do not fully mimic real tissues. New 3D technologies, like bioprinting, offer better methods to study these diseases, improve drug testing, and develop personalized treatments, bringing ...
Amelia Heslington, Catharien M. U. Hilkens, Ana Marina Ferreira, Priscila Melo   +3 more
wiley   +1 more source

Anti‐VEGF‐A therapy reduces lymphatic vessel density and expression of VEGFR‐3 in an orthotopic breast tumor model [PDF]

, 2007
Brandt D. Whitehurst, Michael J. Flister, Juhi Bagaitkar, Lisa Volk, C. Bivens, Brent Pickett, Emely Castro‐Rivera, Rolf A. Brekken, Robert D. Gerard, Sophia Ran   +9 more
openalex   +1 more source

Progress and challenges of mRNA vaccines

Interdisciplinary Medicine, Volume 1, Issue 1, January 2023., 2023
As the third‐generation nucleic acid vaccine, the Messenger RNA (mRNA) vaccine stimulates a specific immune response by introducing mRNA expressing the target antigen into the body through a specific delivery system and expressing the corresponding protein.
Liangru Lin, Yusheng Pei, Zhou Li, Dan Luo   +3 more
wiley   +1 more source